More than half of U.S. adults are carriers of HSV1 (herpes simplex virus type 1) which hibernates in the peripheral nervous system and can never be eradicated. A new study has uncovered herpes’ sneaky strategy for infecting the nervous system, opening a door to long-needed vaccine development for both HSV1 and its close sibling HSV2.